Kenalog and Pain - back for Women aged 60+ (a phase IV clinical study of FDA data)

Summary:

Pain - back is found for women aged 60+ who take Kenalog (triamcinolone acetonide). This study is created by eHealthMe based on reports of 2,055 women aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

  • Time on Kenalog when people have Pain - back
  • Top conditions
  • Top co-used drugs
  • Top other side effects


On Jun, 17, 2026

2,055 women aged 60+ reported to have side effects when taking Kenalog.
Among them, 97 people (4.72%) have Pain - back


What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

What is Pain - back?

Pain - back is found to be associated with 4,096 drugs and 4,369 conditions by eHealthMe. Check the latest studies of Pain - back.

Number of reports submitted per year:

Could Kenalog cause Pain - back in women aged 60+?

Time on Kenalog when people have Pain - back *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Severity of Pain - back

n/a

How people recovered from Pain - back

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 24 people, 24.74%
  2. Neoplasm Malignant (cancer tumour): 14 people, 14.43%
  3. Metastases To Spine (cancer spreads to spine): 14 people, 14.43%
  4. Lung Neoplasm (tumour of lung): 14 people, 14.43%
  5. Calcium Deficiency (lack of calcium): 14 people, 14.43%
  6. Joint Pain: 11 people, 11.34%
  7. High Blood Pressure: 7 people, 7.22%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.22%
  9. Thyroid Diseases: 7 people, 7.22%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 6.19%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

  1. Lasix: 49 people, 50.52%
  2. Synthroid: 34 people, 35.05%
  3. Zometa: 33 people, 34.02%
  4. Ativan: 30 people, 30.93%
  5. Aspirin: 29 people, 29.90%
  6. Remicade: 29 people, 29.90%
  7. Peridex: 29 people, 29.90%
  8. Centrum: 29 people, 29.90%
  9. Prednisone: 29 people, 29.90%
  10. Dilaudid: 28 people, 28.87%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

  1. Fatigue (feeling of tiredness): 53 people, 54.64%
  2. Joint Pain: 47 people, 48.45%
  3. Stress And Anxiety: 44 people, 45.36%
  4. Anaemia (lack of blood): 42 people, 43.30%
  5. Infection: 41 people, 42.27%
  6. High Blood Pressure: 39 people, 40.21%
  7. Headache (pain in head): 36 people, 37.11%
  8. Weakness: 36 people, 37.11%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 36 people, 37.11%
  10. Bone Disorder: 35 people, 36.08%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog and have Pain - back?

- Check whether Pain - back is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, triamcinolone acetonide (the active ingredients of Kenalog) and Kenalog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: